Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol.

Trial Profile

Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2010

At a glance

  • Drugs Atenolol; Irbesartan
  • Indications Diabetic angiopathies; Diabetic nephropathies; Hypertension
  • Focus Pharmacodynamics
  • Acronyms IREDIS
  • Sponsors Sanofi
  • Most Recent Events

    • 06 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top